Capturing missed HIV pre-exposure prophylaxis opportunities-sexually transmitted infection diagnoses in the emergency department

被引:3
作者
Mclaughlin, Stephanie E. [1 ]
Kapadia, Farzana [2 ]
Greene, Richard E. [1 ]
Pitts, Robert [1 ]
机构
[1] New York Univ Langone, Dept Med, New York, NY USA
[2] NYU, Dept Epidemiol, Sch Global Publ Hlth, New York, NY USA
关键词
prevention; other; HIV (human immunodeficiency virus); viral disease; North America; location;
D O I
10.1177/09564624211048671
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The United States Centers for Disease Control and Prevention (CDC) recommends HIV pre-exposure prophylaxis (PrEP) be considered for all patients diagnosed with a sexually transmitted infection (STI). Emergency departments (EDs) are an important site for diagnosis and treatment of STIs for under-served populations. Consequently, we identified 377 patients diagnosed with a bacterial sexually transmitted infection (gonorrhea, chlamydia, and/or syphilis) at a major New York City emergency department between 1/1/2014 and 7/30/2017 to examine associations between key sociodemographic characteristics and missed opportunities for PrEP provision. In this sample, 299 (79%) emergency department patients missed their medical follow-up 90 days after STI diagnosis, as recommended. Results from adjusted generalized estimating equation regression models indicate that patients >45 yo (aOR = 2.2, 95% CI 1.2-3.9) and those with a primary care provider in the hospital system (aOR = 6.8, 95% CI 3.8-12.0) were more likely to return for follow-up visits, whereas Black patients (aOR = 0.44, 95% CI 0.25-0.77) were less likely to return for follow-up visits. These findings indicate that lack of STI treatment follow-up visits are significantly missed opportunities for PrEP provision and comprehensive human immunodeficiency virus prevention care.
引用
收藏
页码:242 / 246
页数:5
相关论文
共 50 条
  • [41] The Cost-effectiveness of Pre-Exposure Prophylaxis for HIV Infection in South African Women
    Walensky, Rochelle P.
    Park, Ji-Eun
    Wood, Robin
    Freedberg, Kenneth A.
    Scott, Callie A.
    Bekker, Linda-Gail
    Losina, Elena
    Mayer, Kenneth H.
    Seage, George R., III
    Paltiel, A. David
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (10) : 1504 - 1513
  • [42] Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial
    Jenell Stewart
    Elizabeth Bukusi
    Fredericka A. Sesay
    Kevin Oware
    Deborah Donnell
    Olusegun O. Soge
    Connie Celum
    Josephine Odoyo
    Zachary A. Kwena
    Caitlin W. Scoville
    Lauren R. Violette
    Susan Morrison
    Jane Simoni
    R. Scott McClelland
    Ruanne Barnabas
    Monica Gandhi
    Jared M. Baeten
    Trials, 23
  • [43] Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial
    Stewart, Jenell
    Bukusi, Elizabeth
    Sesay, Fredericka A.
    Oware, Kevin
    Donnell, Deborah
    Soge, Olusegun O.
    Celum, Connie
    Odoyo, Josephine
    Kwena, Zachary A.
    Scoville, Caitlin W.
    Violette, Lauren R.
    Morrison, Susan
    Simoni, Jane
    McClelland, R. Scott
    Barnabas, Ruanne
    Gandhi, Monica
    Baeten, Jared M.
    TRIALS, 2022, 23 (01)
  • [44] Sexually Transmitted Infections Among Men and Transgender Women Using HIV Pre-exposure Prophylaxis in a Large Integrated Health System-A Cohort Study
    Hechter, Rulin C.
    Bruxvoort, Katia J.
    Zhou, Hui
    Towner, William J.
    Contreras, Richard
    Schumacher, Christina M.
    Grant, Deborah L.
    Jones, Joyce
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 91 (01) : 1 - 8
  • [45] Targeted Screening for HIV Pre-Exposure Prophylaxis Eligibility in Two Emergency Departments in Washington, DC
    Kulie, Paige
    Castel, Amanda D.
    Zheng, Zhaonian
    Powell, Natasha N.
    Srivastava, Aneil
    Chandar, Sandhya
    McCarthy, Melissa L.
    AIDS PATIENT CARE AND STDS, 2020, 34 (12) : 516 - 522
  • [46] Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection - A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis
    Werner, Ricardo Niklas
    Gaskins, Matthew
    Nast, Alexander
    Dressler, Corinna
    PLOS ONE, 2018, 13 (12):
  • [47] Acceptability of a Tenofovir Disoproxil Fumarate Intravaginal Ring for HIV Pre-Exposure Prophylaxis Among Sexually Active Women
    Dobkin, April
    McWalters, Jessica
    Barnett, Rebecca
    Ray, Laurie L.
    Espinoza, Lilia
    McGinn, Aileen P.
    Atrio, Jessica M.
    Keller, Marla J.
    SEXUALLY TRANSMITTED DISEASES, 2020, 47 (12) : 819 - 824
  • [48] Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016
    Moreno, Santiago
    Antela, Antonio
    Garcia, Felipe
    del Amo, Julia
    Boix, Vicente
    Coll, Pep
    Fortuny, Claudia
    Gomez Sirvent, Juan L.
    Gutierrez, Felix
    Iribarren, Jose A.
    Llibre, Josep M.
    Bernaldo de Quiros, Juan C. Lopez
    Emilio Losa, Juan
    Lozano, Ana
    Meulbroek, Michael
    Olalla, Julian
    Pujol, Ferran
    Pulido, Federico
    Crespo Casal, Manuel
    Gonzalez Garcia, Juan
    Lopez Aldeguer, Jose
    Perez Molina, Jose A.
    Podzamczer Palter, Daniel
    Rivero Roman, Antonio
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2017, 35 (06): : 377 - 383
  • [49] Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now
    Mofenson, Lynne M.
    PLOS MEDICINE, 2016, 13 (09)
  • [50] HIV pre-exposure prophylaxis and the 'problems' of reduced condom use and sexually transmitted infections in Australia: a critical analysis from an evidence-making intervention perspective
    Holt, Martin
    Newman, Christy E.
    Lancaster, Kari
    Smith, Anthony K.
    Hughes, Shana
    Truong, Hong-Ha M.
    SOCIOLOGY OF HEALTH & ILLNESS, 2019, 41 (08) : 1535 - 1548